Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIV

Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population. Limited data exist on relationships between plasma OPN and surrogates of HIV-associated heart failure risk. Prospective, cross-sectional. We...

Full description

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 37; no. 2; pp. 305 - 310
Main Authors Robinson, Jake A, Toribio, Mabel, Quinaglia, Thiago, Awadalla, Magid, Talathi, Ria, Durbin, Claudia G, Alhallak, Iad, Alagpulinsa, David A, Fourman, Lindsay T, Suero-Abreu, Giselle Alexandra, Nelson, Michael D, Stanley, Takara L, Longenecker, Christopher T, Szczepaniak, Lidia S, Jerosch-Herold, Michael, Neilan, Tomas G, Zanni, Markella V, Burdo, Tricia H
Format Journal Article
LanguageEnglish
Published England 01.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population. Limited data exist on relationships between plasma OPN and surrogates of HIV-associated heart failure risk. Prospective, cross-sectional. We analyzed relationships between plasma OPN and cardiac structure/function (assessed using cardiovascular magnetic resonance imaging) and immune activation (biomarkers and flow cytometry) among 20 WWH and 14 women without HIV (WWOH). Plasma OPN did not differ between groups. Among WWH, plasma OPN related directly to the markers of cardiac fibrosis, growth differentiation factor-15 (ρ = 0.51, P = 0.02) and soluble interleukin 1 receptor-like 1 (ρ = 0.45, P = 0.0459). Among WWH (but not among WWOH or the whole group), plasma OPN related directly to both myocardial fibrosis (ρ = 0.49, P = 0.03) and myocardial steatosis (ρ = 0.46, P = 0.0487). Among the whole group and WWH (and not among WWOH), plasma OPN related directly to the surface expression of C-X3-C motif chemokine receptor 1 (CX3CR1) on nonclassical (CD14-CD16+) monocytes (whole group: ρ = 0.36, P = 0.04; WWH: ρ = 0.46, P = 0.04). Further, among WWH and WWOH (and not among the whole group), plasma OPN related directly to the surface expression of CC motif chemokine receptor 2 (CCR2) on inflammatory (CD14+CD16+) monocytes (WWH: ρ = 0.54, P = 0.01; WWOH: ρ = 0.60, P = 0.03), and in WWH, this held even after controlling for HIV-specific parameters. Among WWH, plasma OPN, a powerful predictor of heart failure outcomes, related to myocardial fibrosis and steatosis and the expression of CCR2 and CX3CR1 on select monocyte subpopulations. OPN may play a role in heart failure pathogenesis among WWH. NCT02874703.
AbstractList Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population. Limited data exist on relationships between plasma OPN and surrogates of HIV-associated heart failure risk.OBJECTIVEWomen with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population. Limited data exist on relationships between plasma OPN and surrogates of HIV-associated heart failure risk.Prospective, cross-sectional.DESIGNProspective, cross-sectional.We analyzed relationships between plasma OPN and cardiac structure/function (assessed using cardiovascular magnetic resonance imaging) and immune activation (biomarkers and flow cytometry) among 20 WWH and 14 women without HIV (WWOH).METHODSWe analyzed relationships between plasma OPN and cardiac structure/function (assessed using cardiovascular magnetic resonance imaging) and immune activation (biomarkers and flow cytometry) among 20 WWH and 14 women without HIV (WWOH).Plasma OPN did not differ between groups. Among WWH, plasma OPN related directly to the markers of cardiac fibrosis, growth differentiation factor-15 (ρ = 0.51, P = 0.02) and soluble interleukin 1 receptor-like 1 (ρ = 0.45, P = 0.0459). Among WWH (but not among WWOH or the whole group), plasma OPN related directly to both myocardial fibrosis (ρ = 0.49, P = 0.03) and myocardial steatosis (ρ = 0.46, P = 0.0487). Among the whole group and WWH (and not among WWOH), plasma OPN related directly to the surface expression of C-X3-C motif chemokine receptor 1 (CX3CR1) on nonclassical (CD14-CD16+) monocytes (whole group: ρ = 0.36, P = 0.04; WWH: ρ = 0.46, P = 0.04). Further, among WWH and WWOH (and not among the whole group), plasma OPN related directly to the surface expression of CC motif chemokine receptor 2 (CCR2) on inflammatory (CD14+CD16+) monocytes (WWH: ρ = 0.54, P = 0.01; WWOH: ρ = 0.60, P = 0.03), and in WWH, this held even after controlling for HIV-specific parameters.RESULTSPlasma OPN did not differ between groups. Among WWH, plasma OPN related directly to the markers of cardiac fibrosis, growth differentiation factor-15 (ρ = 0.51, P = 0.02) and soluble interleukin 1 receptor-like 1 (ρ = 0.45, P = 0.0459). Among WWH (but not among WWOH or the whole group), plasma OPN related directly to both myocardial fibrosis (ρ = 0.49, P = 0.03) and myocardial steatosis (ρ = 0.46, P = 0.0487). Among the whole group and WWH (and not among WWOH), plasma OPN related directly to the surface expression of C-X3-C motif chemokine receptor 1 (CX3CR1) on nonclassical (CD14-CD16+) monocytes (whole group: ρ = 0.36, P = 0.04; WWH: ρ = 0.46, P = 0.04). Further, among WWH and WWOH (and not among the whole group), plasma OPN related directly to the surface expression of CC motif chemokine receptor 2 (CCR2) on inflammatory (CD14+CD16+) monocytes (WWH: ρ = 0.54, P = 0.01; WWOH: ρ = 0.60, P = 0.03), and in WWH, this held even after controlling for HIV-specific parameters.Among WWH, plasma OPN, a powerful predictor of heart failure outcomes, related to myocardial fibrosis and steatosis and the expression of CCR2 and CX3CR1 on select monocyte subpopulations. OPN may play a role in heart failure pathogenesis among WWH.CONCLUSIONAmong WWH, plasma OPN, a powerful predictor of heart failure outcomes, related to myocardial fibrosis and steatosis and the expression of CCR2 and CX3CR1 on select monocyte subpopulations. OPN may play a role in heart failure pathogenesis among WWH.NCT02874703.CLINICALTRIALSGOV REGISTRATIONNCT02874703.
Objective: Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population. Limited data exist on relationships between plasma OPN and surrogates of HIV-associated heart failure risk. Design: Prospective, cross-sectional. Methods: We analyzed relationships between plasma OPN and cardiac structure/function (assessed using cardiovascular magnetic resonance imaging) and immune activation (biomarkers and flow cytometry) among 20 WWH and 14 women without HIV (WWOH). Results: Plasma OPN did not differ between groups. Among WWH, plasma OPN related directly to the markers of cardiac fibrosis, growth differentiation factor-15 ( ρ = 0.51, P = 0.02) and soluble interleukin 1 receptor-like 1 ( ρ = 0.45, P = 0.0459). Among WWH (but not among WWOH or the whole group), plasma OPN related directly to both myocardial fibrosis ( ρ = 0.49, P = 0.03) and myocardial steatosis ( ρ = 0.46, P = 0.0487). Among the whole group and WWH (and not among WWOH), plasma OPN related directly to the surface expression of C-X3-C motif chemokine receptor 1 (CX3CR1) on nonclassical (CD14 − CD16 + ) monocytes (whole group: ρ = 0.36, P = 0.04; WWH: ρ = 0.46, P = 0.04). Further, among WWH and WWOH (and not among the whole group), plasma OPN related directly to the surface expression of CC motif chemokine receptor 2 (CCR2) on inflammatory (CD14 + CD16 + ) monocytes (WWH: ρ = 0.54, P = 0.01; WWOH: ρ = 0.60, P = 0.03), and in WWH, this held even after controlling for HIV-specific parameters. Conclusion: Among WWH, plasma OPN, a powerful predictor of heart failure outcomes, related to myocardial fibrosis and steatosis and the expression of CCR2 and CX3CR1 on select monocyte subpopulations. OPN may play a role in heart failure pathogenesis among WWH. Clinicaltrials.gov Registration: NCT02874703.
Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population. Limited data exist on relationships between plasma OPN and surrogates of HIV-associated heart failure risk. Prospective, cross-sectional. We analyzed relationships between plasma OPN and cardiac structure/function (assessed using cardiovascular magnetic resonance imaging) and immune activation (biomarkers and flow cytometry) among 20 WWH and 14 women without HIV (WWOH). Plasma OPN did not differ between groups. Among WWH, plasma OPN related directly to the markers of cardiac fibrosis, growth differentiation factor-15 (ρ = 0.51, P = 0.02) and soluble interleukin 1 receptor-like 1 (ρ = 0.45, P = 0.0459). Among WWH (but not among WWOH or the whole group), plasma OPN related directly to both myocardial fibrosis (ρ = 0.49, P = 0.03) and myocardial steatosis (ρ = 0.46, P = 0.0487). Among the whole group and WWH (and not among WWOH), plasma OPN related directly to the surface expression of C-X3-C motif chemokine receptor 1 (CX3CR1) on nonclassical (CD14-CD16+) monocytes (whole group: ρ = 0.36, P = 0.04; WWH: ρ = 0.46, P = 0.04). Further, among WWH and WWOH (and not among the whole group), plasma OPN related directly to the surface expression of CC motif chemokine receptor 2 (CCR2) on inflammatory (CD14+CD16+) monocytes (WWH: ρ = 0.54, P = 0.01; WWOH: ρ = 0.60, P = 0.03), and in WWH, this held even after controlling for HIV-specific parameters. Among WWH, plasma OPN, a powerful predictor of heart failure outcomes, related to myocardial fibrosis and steatosis and the expression of CCR2 and CX3CR1 on select monocyte subpopulations. OPN may play a role in heart failure pathogenesis among WWH. NCT02874703.
Author Nelson, Michael D
Longenecker, Christopher T
Toribio, Mabel
Szczepaniak, Lidia S
Jerosch-Herold, Michael
Quinaglia, Thiago
Awadalla, Magid
Stanley, Takara L
Zanni, Markella V
Suero-Abreu, Giselle Alexandra
Burdo, Tricia H
Robinson, Jake A
Alagpulinsa, David A
Alhallak, Iad
Fourman, Lindsay T
Talathi, Ria
Neilan, Tomas G
Durbin, Claudia G
Author_xml – sequence: 1
  givenname: Jake A
  surname: Robinson
  fullname: Robinson, Jake A
  organization: Department of Microbiology, Immunology, and Inflammation, Center for Neurovirology and Gene Editing, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
– sequence: 2
  givenname: Mabel
  surname: Toribio
  fullname: Toribio, Mabel
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 3
  givenname: Thiago
  surname: Quinaglia
  fullname: Quinaglia, Thiago
  organization: Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology
– sequence: 4
  givenname: Magid
  surname: Awadalla
  fullname: Awadalla, Magid
  organization: Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology
– sequence: 5
  givenname: Ria
  surname: Talathi
  fullname: Talathi, Ria
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 6
  givenname: Claudia G
  surname: Durbin
  fullname: Durbin, Claudia G
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 7
  givenname: Iad
  surname: Alhallak
  fullname: Alhallak, Iad
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 8
  givenname: David A
  surname: Alagpulinsa
  fullname: Alagpulinsa, David A
  organization: Vaccine and Immunotherapy Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA
– sequence: 9
  givenname: Lindsay T
  surname: Fourman
  fullname: Fourman, Lindsay T
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 10
  givenname: Giselle Alexandra
  surname: Suero-Abreu
  fullname: Suero-Abreu, Giselle Alexandra
  organization: Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology
– sequence: 11
  givenname: Michael D
  surname: Nelson
  fullname: Nelson, Michael D
  organization: Applied Physiology and Advanced Imaging Laboratory, Department of Kinesiology, University of Texas at Arlington, Arlington, TX
– sequence: 12
  givenname: Takara L
  surname: Stanley
  fullname: Stanley, Takara L
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 13
  givenname: Christopher T
  surname: Longenecker
  fullname: Longenecker, Christopher T
  organization: Division of Cardiology and Department of Global Health, University of Washington, Seattle, WA
– sequence: 14
  givenname: Lidia S
  surname: Szczepaniak
  fullname: Szczepaniak, Lidia S
  organization: MRS Consulting in Biomedical Research, Albuquerque, NM
– sequence: 15
  givenname: Michael
  surname: Jerosch-Herold
  fullname: Jerosch-Herold, Michael
  organization: Division of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
– sequence: 16
  givenname: Tomas G
  surname: Neilan
  fullname: Neilan, Tomas G
  organization: Cardiovascular Imaging Research Center (CIRC), Department of Radiology and Division of Cardiology
– sequence: 17
  givenname: Markella V
  surname: Zanni
  fullname: Zanni, Markella V
  organization: Metabolism Unit, Division of Endocrinology
– sequence: 18
  givenname: Tricia H
  surname: Burdo
  fullname: Burdo, Tricia H
  organization: Department of Microbiology, Immunology, and Inflammation, Center for Neurovirology and Gene Editing, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36541642$$D View this record in MEDLINE/PubMed
BookMark eNpdkNtKAzEQhoNU7EHfQCSX3mzNaZPtZamHCgUV1Nslu8lqZJPUTdbStzfSWsS5GWb4_jn8YzBw3mkAzjGaYjQTV0_z6yn6E5RhcQRGmAma5bnAAzBChM-yGRVoCMYhfCQoR0VxAoaU5wxzRkbAPrYyWAl9iNqvvYvGwU63MuoAo4d262vZKSNb2Jiq88EEKJ2CiZbxUCXQWNs7DWUdzZeMxjsorXdvcOOtdnBj4jtc3r-eguNGtkGf7fMEvNzePC-W2erh7n4xX2U1RSJmnMhZgxgmeYOpUKSqakxww4rUwYVgiqTzK0mkwoohLBhFHHGKBddKCFbRCbjczV13_rPXIZbWhFq3rXTa96EkIudcoALhhLIdWqfvQqebct0ZK7ttiVH5Y3SZjC7_G51kF_sNfWW1Ooh-naXfcE96ZA
CitedBy_id crossref_primary_10_1161_CIRCRESAHA_124_323890
crossref_primary_10_1097_QAD_0000000000003445
crossref_primary_10_1093_infdis_jiad149
Cites_doi 10.1161/01.CIR.96.9.3063
10.1002/path.1917
10.1161/JAHA.116.003989
10.1161/JAHA.120.018767
10.1161/CIRCHEARTFAILURE.107.746172
10.1161/ATVBAHA.107.144824
10.1016/j.ceca.2020.102265
10.1097/QAI.0000000000002629
10.1186/2050-7771-2-1
10.1182/blood-2012-05-433946
10.1097/CRD.0b013e3181cfb646
10.3389/fimmu.2018.01930
10.1161/CIRCHEARTFAILURE.110.960716
10.1152/physrev.00008.2011
10.3389/fviro.2021.690360
10.1097/QAI.0000000000001917
10.1371/journal.pone.0156965
10.1093/infdis/jir520
10.1007/s11010-008-9939-6
10.1002/hep4.1237
10.1016/j.cytogfr.2008.08.001
10.1161/ATVBAHA.118.311577
10.1161/JAHA.118.009985
10.1097/MD.0000000000027157
10.1093/cvr/cvt100
10.1002/jlb.67.5.699
10.1161/CIRCRESAHA.107.160408
10.1007/s10741-010-9158-6
10.1161/01.HYP.33.2.663
10.1136/hrt.2005.081406
10.1210/jc.2019-01096
ContentType Journal Article
Copyright Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1097/QAD.0000000000003417
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-5571
EndPage 310
ExternalDocumentID 10_1097_QAD_0000000000003417
36541642
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL130539
– fundername: NICHD NIH HHS
  grantid: K23 HD100266
– fundername: NHLBI NIH HHS
  grantid: R01 HL137562
– fundername: NHLBI NIH HHS
  grantid: R01 HL146267
– fundername: NCATS NIH HHS
  grantid: UL1 TR001102
– fundername: NIDDK NIH HHS
  grantid: P30 DK040561
– fundername: NHLBI NIH HHS
  grantid: R01 HL141132
– fundername: NIAID NIH HHS
  grantid: K24 AI157882
– fundername: NIMH NIH HHS
  grantid: T32 MH079785
– fundername: NHLBI NIH HHS
  grantid: K24 HL150238
GroupedDBID ---
.XZ
.Z2
01R
0R~
1J1
23M
2WC
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
85S
8L-
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAXQO
ABASU
ABBUW
ABDIG
ABIVO
ABJNI
ABVCZ
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACILI
ACLDA
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
AE6
AEBDS
AENEX
AFDTB
AFEXH
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJIOK
AJNWD
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BAWUL
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
E.X
E3Z
EBS
ECM
EEVPB
EIF
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
NPM
N~7
N~B
O9-
OAG
OAH
OBH
ODA
ODMTH
OHH
OHYEH
OJAPA
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OPX
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RIG
RLZ
S4R
S4S
SJN
TEORI
TR2
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c307t-62a9f04125f137d2bbc121f481251874d2541ba2ad1d40174306063176ed774b3
ISSN 0269-9370
1473-5571
IngestDate Sat Oct 26 04:56:16 EDT 2024
Wed Aug 28 12:34:54 EDT 2024
Sat Nov 02 12:29:24 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c307t-62a9f04125f137d2bbc121f481251874d2541ba2ad1d40174306063176ed774b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 36541642
PQID 2756670801
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_2756670801
crossref_primary_10_1097_QAD_0000000000003417
pubmed_primary_36541642
PublicationCentury 2000
PublicationDate 2023-02-01
2023-02-1
20230201
PublicationDateYYYYMMDD 2023-02-01
PublicationDate_xml – month: 02
  year: 2023
  text: 2023-02-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle AIDS (London)
PublicationTitleAlternate AIDS
PublicationYear 2023
References Graf (R25-20240815) 1997; 96
Waller (R11-20240815) 2010; 18
Lopez (R22-20240815) 2013; 99
Wang (R10-20240815) 2008; 19
Frangogiannis (R9-20240815) 2012; 92
Chen (R14-20240815) 2021; 87
Toribio (R17-20240815) 2019; 104
Tromp (R6-20240815) 2017; 6
Scatena (R7-20240815) 2007; 27
Lok (R8-20240815) 2019; 39
Singh (R24-20240815) 2010; 15
Zanni (R16-20240815) 2019; 221
Singh (R23-20240815) 1999; 33
Glass (R26-20240815) 2018; 2
Feinstein (R1-20240815) 2018; 7
Weber (R31-20240815) 2000; 67
Krum (R3-20240815) 2011; 4
Yang (R29-20240815) 2014; 2
Mahmud (R15-20240815) 2021; 1
Funderburg (R28-20240815) 2012; 120
Yen (R2-20240815) 2019; 80
Krishnamurthy (R21-20240815) 2009; 322
Burdo (R12-20240815) 2011; 204
Lenga (R20-20240815) 2008; 102
Yang (R32-20240815) 2020; 91
Merlini (R13-20240815) 2021; 100
Rosenberg (R5-20240815) 2008; 1
Kipke (R18-20240815) 2021; 10
Abdalrhim (R4-20240815) 2016; 11
Banerjee (R27-20240815) 2006; 208
Ruytinx (R30-20240815) 2018; 9
Arnlov (R19-20240815) 2006; 92
References_xml – volume: 221
  start-page: 1315
  year: 2019
  ident: R16-20240815
  article-title: Immune correlates of diffuse myocardial fibrosis and diastolic dysfunction among aging women with human immunodeficiency virus
  publication-title: J Infect Dis
  contributor:
    fullname: Zanni
– volume: 96
  start-page: 3063
  year: 1997
  ident: R25-20240815
  article-title: Myocardial osteopontin expression is associated with left ventricular hypertrophy
  publication-title: Circulation
  doi: 10.1161/01.CIR.96.9.3063
  contributor:
    fullname: Graf
– volume: 208
  start-page: 473
  year: 2006
  ident: R27-20240815
  article-title: Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease
  publication-title: J Pathol
  doi: 10.1002/path.1917
  contributor:
    fullname: Banerjee
– volume: 6
  start-page: e003989
  year: 2017
  ident: R6-20240815
  article-title: Biomarker profiles in heart failure patients with preserved and reduced ejection fraction
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.116.003989
  contributor:
    fullname: Tromp
– volume: 10
  start-page: e018767
  year: 2021
  ident: R18-20240815
  article-title: Sex, HIV status, and measures of cardiac stress and fibrosis in Uganda
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.120.018767
  contributor:
    fullname: Kipke
– volume: 1
  start-page: 43
  year: 2008
  ident: R5-20240815
  article-title: Osteopontin, a new prognostic biomarker in patients with chronic heart failure
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.107.746172
  contributor:
    fullname: Rosenberg
– volume: 27
  start-page: 2302
  year: 2007
  ident: R7-20240815
  article-title: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.107.144824
  contributor:
    fullname: Scatena
– volume: 91
  start-page: 102265
  year: 2020
  ident: R32-20240815
  article-title: A novel role of FKN/CX3CR1 in promoting osteogenic transformation of VSMCs and atherosclerotic calcification
  publication-title: Cell Calcium
  doi: 10.1016/j.ceca.2020.102265
  contributor:
    fullname: Yang
– volume: 87
  start-page: 741
  year: 2021
  ident: R14-20240815
  article-title: Human immunodeficiency virus infection and incident heart failure: a meta-analysis of prospective studies
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000002629
  contributor:
    fullname: Chen
– volume: 2
  start-page: 1
  year: 2014
  ident: R29-20240815
  article-title: Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases
  publication-title: Biomark Res
  doi: 10.1186/2050-7771-2-1
  contributor:
    fullname: Yang
– volume: 120
  start-page: 4599
  year: 2012
  ident: R28-20240815
  article-title: Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome
  publication-title: Blood
  doi: 10.1182/blood-2012-05-433946
  contributor:
    fullname: Funderburg
– volume: 18
  start-page: 125
  year: 2010
  ident: R11-20240815
  article-title: Osteopontin in cardiovascular disease: a potential therapeutic target
  publication-title: Cardiol Rev
  doi: 10.1097/CRD.0b013e3181cfb646
  contributor:
    fullname: Waller
– volume: 9
  start-page: 1930
  year: 2018
  ident: R30-20240815
  article-title: Chemokine-induced macrophage polarization in inflammatory conditions
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01930
  contributor:
    fullname: Ruytinx
– volume: 4
  start-page: 561
  year: 2011
  ident: R3-20240815
  article-title: Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy
  publication-title: Circ Heart Fail
  doi: 10.1161/CIRCHEARTFAILURE.110.960716
  contributor:
    fullname: Krum
– volume: 92
  start-page: 635
  year: 2012
  ident: R9-20240815
  article-title: Matricellular proteins in cardiac adaptation and disease
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00008.2011
  contributor:
    fullname: Frangogiannis
– volume: 1
  start-page: 690360
  year: 2021
  ident: R15-20240815
  article-title: Complex interactions between human immunodeficiency virus type-1, sex, and osteopontin influence viral replication and leukocyte proportions in tissues
  publication-title: Front Virol
  doi: 10.3389/fviro.2021.690360
  contributor:
    fullname: Mahmud
– volume: 80
  start-page: 255
  year: 2019
  ident: R2-20240815
  article-title: Human immunodeficiency virus increases the risk of incident heart failure
  publication-title: J Acquir Immune Defic Syndr
  doi: 10.1097/QAI.0000000000001917
  contributor:
    fullname: Yen
– volume: 11
  start-page: e0156965
  year: 2016
  ident: R4-20240815
  article-title: Plasma osteopontin levels and adverse cardiovascular outcomes in the PEACE Trial
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0156965
  contributor:
    fullname: Abdalrhim
– volume: 204
  start-page: 1227
  year: 2011
  ident: R12-20240815
  article-title: Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jir520
  contributor:
    fullname: Burdo
– volume: 322
  start-page: 53
  year: 2009
  ident: R21-20240815
  article-title: Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-008-9939-6
  contributor:
    fullname: Krishnamurthy
– volume: 2
  start-page: 1344
  year: 2018
  ident: R26-20240815
  article-title: Serum interleukin-8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1237
  contributor:
    fullname: Glass
– volume: 19
  start-page: 333
  issue: (5–6)
  year: 2008
  ident: R10-20240815
  article-title: Osteopontin: role in immune regulation and stress responses
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2008.08.001
  contributor:
    fullname: Wang
– volume: 39
  start-page: 613
  year: 2019
  ident: R8-20240815
  article-title: Osteopontin in vascular disease
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.118.311577
  contributor:
    fullname: Lok
– volume: 7
  start-page: e009985
  year: 2018
  ident: R1-20240815
  article-title: Adjudicated heart failure in HIV-infected and uninfected men and women
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.118.009985
  contributor:
    fullname: Feinstein
– volume: 100
  start-page: e27157
  year: 2021
  ident: R13-20240815
  article-title: Predictors of low ovarian reserve in cART-treated women living with HIV
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000027157
  contributor:
    fullname: Merlini
– volume: 99
  start-page: 111
  year: 2013
  ident: R22-20240815
  article-title: Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvt100
  contributor:
    fullname: Lopez
– volume: 67
  start-page: 699
  year: 2000
  ident: R31-20240815
  article-title: Differential chemokine receptor expression and function in human monocyte subpopulations
  publication-title: J Leukoc Biol
  doi: 10.1002/jlb.67.5.699
  contributor:
    fullname: Weber
– volume: 102
  start-page: 319
  year: 2008
  ident: R20-20240815
  article-title: Osteopontin expression is required for myofibroblast differentiation
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.107.160408
  contributor:
    fullname: Lenga
– volume: 15
  start-page: 487
  year: 2010
  ident: R24-20240815
  article-title: Role of osteopontin in heart failure associated with aging
  publication-title: Heart Fail Rev
  doi: 10.1007/s10741-010-9158-6
  contributor:
    fullname: Singh
– volume: 33
  start-page: 663
  year: 1999
  ident: R23-20240815
  article-title: Myocardial osteopontin expression coincides with the development of heart failure
  publication-title: Hypertension
  doi: 10.1161/01.HYP.33.2.663
  contributor:
    fullname: Singh
– volume: 92
  start-page: 1514
  year: 2006
  ident: R19-20240815
  article-title: Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study
  publication-title: Heart
  doi: 10.1136/hrt.2005.081406
  contributor:
    fullname: Arnlov
– volume: 104
  start-page: 6090
  year: 2019
  ident: R17-20240815
  article-title: Intramyocardial triglycerides among women with vs. without HIV: hormonal correlates and functional consequences
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2019-01096
  contributor:
    fullname: Toribio
SSID ssj0005088
Score 2.468289
Snippet Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general population....
Objective: Women with HIV (WWH) have heightened heart failure risk. Plasma OPN (osteopontin) is a powerful predictor of heart failure outcomes in the general...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 305
SubjectTerms Cross-Sectional Studies
Female
Fibrosis
Heart Failure
HIV Infections - complications
Humans
Monocytes - metabolism
Osteopontin - metabolism
Prospective Studies
Receptors, Chemokine
Title Plasma osteopontin relates to myocardial fibrosis and steatosis and to immune activation among women with HIV
URI https://www.ncbi.nlm.nih.gov/pubmed/36541642
https://www.proquest.com/docview/2756670801
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF5BkRAviJuUQ4vEG9oSr491HiPaKiltocJBebO8h4OF4q1SRwh-PbOHDyBIBT9Y9sp2op1PszOz880g9JqF3JSMiQhNU0kAFIKkSoyJiFKZMDlhgSXSnp0ns0V0soyXfeqQZZc0_ED82Mkr-R-pwhjI1bBk_0Gy3UdhAK5BvnAGCcP5WjL-CKbvunhjeBr6UpueD46b4so2rL_DOrWxxJASnGJtSo_YMHljPO32Dh6sDEfEldVwAVrfgshWZ3CR2tn889CMnc4PPw2bgXTRhCGd7KT4qvpQaaY3Fa-04wdx1SV2XGyrulj5nN3sS1WsdAfCb4U0cX73zsrn3vsQBQ3brOZOq0YsJHHseq0cqB1jXhW7-i8ecnSgV0PLzf5T37s6whfTQ1eH0h-wMrN-fWv39M8_5MeL09M8O1pmN9EtCprJ7uvP3_c5QWPbqLT7by3XcsLe7vqNX22Zvzgo1lDJ7qG73sPAUweX--iGqh-g22c-h-IhWjvU4AFqsEcNbjTuUYNb1GDACe5QY-_gQYca3KMGW9RgixpsUIMBNY_Q4vgoezcjvukGEaDuG5LQYlKaImxxGYRMUs5FQIMySo0lnLJI0jgKeEELGUjwzcEAHYMPDFZooiS4Ejx8jPZqXaunCJc8SUw9_zjkZSRKkQpYPZgw3a5pOYnFCJF2-vJLV1slb3MiYLrz36d7hF61c5yDEjQ7W0Wt9PYqNz0MEgbOTzBCT9zkd18MTad78LL3r_H2M3Snx-9ztNdstuoFGJ0Nf2mB8hMKLH4L
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+osteopontin+relates+to+myocardial+fibrosis+and+steatosis+and+to+immune+activation+among+women+with+HIV&rft.jtitle=AIDS+%28London%29&rft.au=Robinson%2C+Jake+A&rft.au=Toribio%2C+Mabel&rft.au=Quinaglia%2C+Thiago&rft.au=Awadalla%2C+Magid&rft.date=2023-02-01&rft.issn=1473-5571&rft.eissn=1473-5571&rft.volume=37&rft.issue=2&rft.spage=305&rft_id=info:doi/10.1097%2FQAD.0000000000003417&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-9370&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-9370&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-9370&client=summon